Long-term postmenopausal hormone use, obesity, and fat distribution in older women

JAMA

Volumn 275, Issue 1, 1996, Pages 46-49

  Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0030023219     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.1.46     Document Type: Article

References (26)

1. Kuller L, Meilahn EN, Gutai J, et al. Lipoproteins, estrogens, and the menopause. In. Korenman SG, ed. The Menopause: Biological and Clinical Consequences of Ovarian Failure: Evolution and Management Norwell, Mass: Serono Symposia USA; 1990.
2. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga PL. Weight gain at the time of menopause. Arch Intern Med. 1991;151:97-102.
3. Stampfer MJ, Willett WC, Colditz GA, Rossner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985;313:1044-1049.
4. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641-646.
5. Notelovitz M. The effect of oral oestrogens on blood pressure and weight in postmenopausal women. S Afr Med J. 1975;49:2251-2254.
6. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74-79.
7. Utian WH. Effect of postmenopausal estrogen therapy on diastolic blood pressure and body weight. Maturitas. 1978;1:3-8.
8. Hart DM, Lindsay R, Purdie D. Vascular complications of long-term oestrogen therapy. Front Horm Res. 1978;5:174-191.
9. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
10. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism. 1991;40:1323-1326.
11. Kaye SA, Folsom AR, Prineas EJ, Potter JD, Gapstur SM. The association of body fat distribution with lifestyle and reproductive factors in a population study of postmenopausal women. Int J Obes. 1990;14:583-591.
12. Tonkelaar ID, Seidell JC, Van Noord PAH, Baanders-van Halewijn EA, Jacobus JH, Bruning PF. Factors influencing waist/hip ratio in randomly selected pre- and post-menopausal women in the DOM-project (preliminary results). Int J Obes. 1989;13:817-824.
13. Wing RR, Matthews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle aged women: associations with behavioral and psychosocial factors and with changes in cardiovascular risk factors. Arterioscler Thromb. 1991;11:1250-1257.
14. Tonkelaar ID, Seidell JC, Van Noord PAH, Baanders-van Halewijn EA, Ouwehand IJ. Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: a cross-sectional study in 11,825 Dutch women participating in the DOM-Project. Int J Obes. 1990;14:753-761.
15. Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism. 1989;38:662-665.
16. Lukaski HC, Johnson PE, Bolonchuek WW, et al. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr, 1985;41:810-817.
17. Kushner RF. Bioelectrical impedance analysis: a review of principles and applications. J Am Coll Nutr 1992;11:199-209.
18. Notelovitz M, Ware MD, Dougherty MC. Blood pressure and body weight of postmenopausal women after one year of estrogen-progestin therapy. Curr Ther Res. 1982;31:746-751.
19. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55:950-954.
20. Londgren H, Bengtsson C, Blohme G, Lapidus L, Sjostrom L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 1989;13:413-423.
21. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ. 1984;289:1257-1261.
22. Hartz AJ, Rupley DC, Kalkhoff RD, Rimm AA. Relationship of obesity to diabetes: influence of obesity level and body fat distribution. Prev Med. 1983;12:351-357.
23. Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 21,065 women. Am J Epidemiol. 1984;119:71-80.
24. Kuller LH, Meilahn EN, Cauley JA, Gutai JP, Matthews KA. Epidemiologic studies of menopause: changes in risk factors and disease. Exp Gerontol. 1994;9:495-509.
25. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history of fasting hyperglycemia. Am J Epidemiol. 1980;111:705-712.
26. Goodman MT, Nomura AM, Wilkens LR, Kolonel LN. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol. 1990;131:815-825.